Delighted to have my paper published in Immunology.
We investigated if/how macrophages from human lungs respond to SARS-CoV-2 spike and envelope proteins, and whether these responses were affected by age or smoking.
@TBImmunologyTCD
https://t.co/bjS7RpsEwC
But it is exciting because it identifies a mechanism that could partly explain why older adults are at such high risk, and be the basis of further treatment and prevention research.
I am absolutely delighted to share our paper showing the induction of trained immunity by an adenoviral COVID-19 vaccine published in @jclinicalinvest this evening! A truly massive thank you to @ShareeBasdeo and the whole team for all their help 🥳🥳 https://t.co/MQvp4Dt1PT
This might explain why previous trials of adjunctive retinol to TB therapy have failed, and suggests that using inhaled exogenous ATRA may unlock vitamin A's efficacy for TB patients
ATRA is produced from circulating retinol at the site of action, but there are several steps needed before ATRA can have its beneficial effects - including two-step oxidation of retinol to ATRA and then delivery of ATRA to its nuclear receptors by carrier proteins.
The red line is what happened to the reported rates of ‘viral-like illness’ - a surrogate for COVID cases - back during the first wave. Look how steeply the curve drops off with widespread buy-in to a lockdown. We did this before and can do it again! #COVID19Ireland
Hydatid disease not endemic in Ireland?
So they say, but myself and Caroline Conlon would beg to differ (new case report).
🐑🪱🐕🪱🧍♂️
What is it about Galway and weird pathology?
https://t.co/6kTWPPQbwA
@HelenTuite1